Gentiva Health Services Inc. GTIV was a big mover last session, as its shares rose nearly 62% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $7.69 to $8.78 in the past one-month timeframe.
In the last 30 days, the company witnessed four estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Gentiva Health Services currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the healthcare industry include Amedisys Inc. AMED, RadNet, Inc. RDNT and PharMerica Corporation PMC. All three sport a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMEDISYS INC AMED: Free Stock Analysis Report
GENTIVA HEALTH GTIV: Free Stock Analysis Report
PHARMERICA CORP PMC: Free Stock Analysis Report
RADNET INC RDNT: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30 days, the company witnessed four estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Gentiva Health Services currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the healthcare industry include Amedisys Inc. AMED, RadNet, Inc. RDNT and PharMerica Corporation PMC. All three sport a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMEDISYS INC AMED: Free Stock Analysis Report
GENTIVA HEALTH GTIV: Free Stock Analysis Report
PHARMERICA CORP PMC: Free Stock Analysis Report
RADNET INC RDNT: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
